Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice

Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice

Muhammed A Saad,1,2 Noha M Eissa,2 Mohammed A Ahmed,3 Aliaa N ElMeshad,3,4 Götz Laible,5– 7 Ahmed S Attia,8 Medhat A Al-Ghobashy,9,10 Rania M Abdelsalam,1,2 Muhammad Y Al-Shorbagy1,11 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2School of Pharmacy...

Full description

Bibliographic Details
Main Authors:	Saad MA, Eissa NM, Ahmed MA, ElMeshad AN, Laible G, Attia AS, Al-Ghobashy MA, Abdelsalam RM, Al-Shorbagy MY
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-09-01
Series:	International Journal of Nanomedicine
Subjects:	multiple sclerosis experimental autoimmune encephalomyelitis nanoparticle rituximab recombinant human myelin basic protein
Online Access:	https://www.dovepress.com/nanoformulated-recombinant-human-myelin-basic-protein-and-rituximab-mo-peer-reviewed-fulltext-article-IJN

Similar Items

Myelin oligodendrocyte glycoprotein encephalomyelitis: An unusual cause of blindness
by: Nimrat Sandhu, et al.
Published: (2022-01-01)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01)

Recurrent myelin oligodendrocyte glycoprotein⁃IgG⁃associated optic neuritis⁃encephalomyelitis: one case report
by: Jing SHA, et al.
Published: (2020-10-01)

Acute Hemorrhagic Encephalomyelitis in the Context of MOG Antibody-Associated Disease. Comment on Chen et al. Rapid Progressive Fatal Acute Hemorrhagic Encephalomyelitis. <i>Diagnostics</i> 2023, <i>13</i>, 2481
by: Sohyeon Kim, et al.
Published: (2023-10-01)

Transient myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis following influenza A infection: A rare case
by: Prashant Nasa, et al.
Published: (2021-01-01)

The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
by: Jie Xu, et al.
Published: (2021-05-01)

Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation
by: Natalie Eaton, et al.
Published: (2018-03-01)

Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses
by: Dariush Haghmorad, et al.
Published: (2022-11-01)

Refractory Fulminant Acute Disseminated Encephalomyelitis (ADEM) in an Adult
by: Jose eBiller, et al.
Published: (2014-12-01)

Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelination
by: Susan L. Lindsay, et al.
Published: (2022-01-01)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
by: M. Moransard, et al.
Published: (2017-10-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as intractable fever managed by bromocriptine: a case report
by: Jin San Lee, et al.
Published: (2023-06-01)

Overview of myelin, major myelin lipids, and myelin-associated proteins
by: Alexander Kister, et al.
Published: (2023-02-01)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
by: Xueshan Dong, et al.
Published: (2023-05-01)

The Wide Variety of Acute Disseminated Encephalomyelitis in Children: A Clinical Perspective
by: Hyunsuk Lim, et al.
Published: (2022-10-01)

Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens
by: Al-ani MR, et al.
Published: (2020-03-01)

TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis
by: Mellanby Richard J, et al.
Published: (2012-10-01)

The potential effects of hemp seed/evening primrose oils on the mammalian target of rapamycin complex 1 and interferon-gamma genes expression in experimental autoimmune encephalomyelitis
by: Soheila Rezapour-Firouzi, et al.
Published: (2018-01-01)

Efficacy and safety of rituximab in central nervous system demyelinating disorders
by: Varsha A Patil, et al.
Published: (2021-01-01)

Clinical and Magnetic Resonance Imaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Meifang Lei, et al.
Published: (2022-05-01)

Acute Disseminated Encephalomyelitis with Measles
by: Ishrat Jahan, et al.
Published: (2013-01-01)

Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis
by: Nathalia Bernardes Teixeira, et al.
Published: (2020-09-01)

A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87–99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis
by: Mary Emmanouil, et al.
Published: (2018-01-01)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
by: Fatemeh Saffari, et al.
Published: (2022-01-01)

Clinical characteristics and associated factors of pediatric acute disseminated encephalomyelitis patients with MOG antibodies: a retrospective study in Hangzhou, China
by: Jue Shen, et al.
Published: (2022-11-01)

Association of New Putative Epitopes of Myelin Proteolipid Protein (58-74) with Pathogenesis of Multiple Sclerosis
by: Zahra Zamanzadeh, et al.
Published: (2016-10-01)

Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options
by: Yun-Jin Lee, et al.
Published: (2021-03-01)

Rituximab Leads to Long Remissions in Patients with Chronic Immune Thrombocytopenia
by: Khalid Al-Habsi, et al.
Published: (2015-03-01)

Rituximab resistance in ITP and beyond
by: Zhengrui Xiao, et al.
Published: (2023-07-01)

Targeted Expression of Myelin Autoantigen in the Periphery Induces Antigen-Specific T and B Cell Tolerance and Ameliorates Autoimmune Disease
by: Shin-Young Na, et al.
Published: (2021-06-01)

Myelin Dynamics Throughout Life: An Ever-Changing Landscape?
by: Jill M. Williamson, et al.
Published: (2018-11-01)

Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules
by: Pei W, et al.
Published: (2018-06-01)

Unraveling Myelin Plasticity
by: Giulia Bonetto, et al.
Published: (2020-06-01)

Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis
by: Maria-Eleni Androutsou, et al.
Published: (2020-10-01)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
by: Leilei Mao, et al.
Published: (2019-08-01)

Generation of a murine model of chronic progressive Experimental Autoimmune Encephalomyelitis for molecular pharmacology studies in Multiple Sclerosis
by: Karelia Macías-Cosme, et al.

Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment
by: Sundararajan Jayaraman, et al.
Published: (2022-10-01)

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives
by: Edgardo E. Espinosa Estrada, et al.
Published: (2010-12-01)

A case of anti-myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin G (IgG) associated disorder (MOGAD) with clinical manifestations of acute disseminated encephalomyelitis: Secondary to mycoplasma pneumoniae infection
by: Xiangui Huang, et al.
Published: (2023-02-01)

A Case of Measles with Encephalomyelitis
by: Ali Irfan Baran, et al.
Published: (2020-09-01)